Sign in

CIK 0001850270 · <br>Emerging growth company

PROKIDNEY CORP.

Sign in to watch
Ticker
PROK
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Cayman Islands
Entity type
operating
EIN
981586514
Phone
336-999-7028
Business address
2000 FRONTIS PLAZA BLVD., SUITE 250, WINSTON-SALEM, NC, 27103
Former names
Social Capital Suvretta Holdings Corp. III
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,067,773
in 1 filing

Net −$1,067,773. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Pereira Brian JG −$1.1M Director sold 100% of stake
Date Insider Transaction Shares Price Value Owned after
2023-10-24 Palihapitiya Chamath 10% owner Sale −176,300 $1.75 $309K 7,664,673
2023-10-23 Palihapitiya Chamath 10% owner Sale −160,300 $1.83 $293K 7,840,973
2023-10-20 Palihapitiya Chamath 10% owner Sale −87,200 $1.92 $168K 8,001,273
2023-10-19 Palihapitiya Chamath 10% owner Sale −200,000 $2.19 $439K 8,088,473
2023-10-18 Palihapitiya Chamath 10% owner Sale −125,100 $2.28 $285K 8,288,473
2023-10-17 Palihapitiya Chamath 10% owner Sale −106,400 $2.83 $301K 8,413,573
2023-10-16 Palihapitiya Chamath 10% owner Sale −215,543 $2.87 $619K 8,519,973
2023-10-13 Palihapitiya Chamath 10% owner Sale −250,000 $2.67 $668K 8,735,516
2023-10-12 Palihapitiya Chamath 10% owner Sale −18,775 $3.14 $59K 9,128,604
2023-10-12 Palihapitiya Chamath 10% owner Sale −143,088 $2.63 $377K 8,985,516
2023-10-11 Palihapitiya Chamath 10% owner Sale −75,000 $3.84 $288K 9,147,379
2023-10-10 Palihapitiya Chamath 10% owner Sale −75,000 $4.34 $325K 9,222,379
2023-10-09 Palihapitiya Chamath 10% owner Sale −75,000 $4.20 $315K 9,297,379
2023-10-06 Palihapitiya Chamath 10% owner Sale −75,000 $4.48 $336K 9,372,379
2023-10-05 Palihapitiya Chamath 10% owner Sale −52,621 $4.76 $251K 9,447,379
2023-09-19 Palihapitiya Chamath 10% owner Sale −1,700,000 $5.47 $9.3M 2,073,000
2023-08-25 Weber Darin J. SVP of Regulatory Development Conversion +137,000 137,000
2023-08-25 Weber Darin J. SVP of Regulatory Development Conversion · Class B Ordinary Shares −137,000 539,356
2023-08-25 Weber Darin J. SVP of Regulatory Development Conversion · Common Units in ProKidney LP −137,000 539,356
2023-08-01 Culleton Bruce EVP, Clinical Development Grant or award · Employee stock option (right to buy) +485,000 485,000

Page 8 of 12 · 231 trades